The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for COVID-19, across the five boroughs, in preparation for a safer back-to-school environment. Through a […]
01
Sep
Sep
ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables revolutionary deoxyribonucleic acid (DNA) mutational profiling of tumor samples. OnkoSight AdvancedNGS testing provides targeted gene content that is aligned with the latest […]
ELMWOOD PARK, N.J., August 18, 2020 – BioReference Laboratories Inc., an OPKO Health Company, is pleased to announce it is now in-network with all Blue Cross and Blue Shield of Texas (BCBSTX) products, including its Health Maintenance Organization (HMO) and Medicaid lines of business. The contract includes BioReference’s subsidiary GeneDx, Inc., a full service genetics […]
12
Aug
Aug
GAITHERSBURG, Md., August 12, 2020 – GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), the global leader in neonatal and pediatric genetic testing, announced the entrance into an agreement with Pediatrix Medical Group (“Pediatrix”), the nation’s leading provider of maternal-fetal, and pediatric medical and surgical subspecialty physician services, to offer state-of-the-art, […]
06
Aug
Aug
GenomeXpress is a rapid genome sequencing test, reporting results within approximately seven days GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ — GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of GenomeXpress, a rapid genome sequencing test. Verbal GenomeXpress results of pathogenic and/or likely pathogenic variants in known disease causing genes are […]
NBA NEW YORK – The NBA announced today a new community testing program providing thousands of no-cost COVID-19 PCR tests in Orlando, Fla. and team markets nationwide. The program, which is a part of NBA Together, the league’s global community and social engagement campaign that aims to support, engage, educate and inspire youth, families and fans […]
Rite Aid CAMP HILL, Pa. (July 29, 2020) – Rite Aid (NYSE: RAD) continues to expand its no-charge COVID-19 testing service with the addition of six drive-through locations opening on July 30 in Michigan and Ohio, through its partnership with the U.S. Department of Health and Human Services (HHS). Like Rite Aid’s existing drive-through testing sites, […]
21
Jul
Jul
ELMWOOD PARK, N.J., July 21, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company, today announced that Geoff Monk, President of BioReference Laboratories, was recognized by CEO Today Magazine as one of this year’s 20 Healthcare Award winners. Every year, CEO Today Magazine identifies and honors the most respected companies and their executives who lead the way on the global stage. CEO Today Magazine’s Healthcare Awards acknowledge […]
CNBC The NFL has selected BioReference Laboratories, a private diagnostics company, to handle coronavirus testing for the entire league this year, Executive Chairman Dr. Jon Cohen told CNBC’s Jim Cramer Monday. “I am not going to discuss the specifics of our relationship right now with the NFL,” he said in an interview on “Mad Money.” “I will […]
20
Jul
Jul
CDC chooses BioReference as one of the antibody testing and service providers for national serological survey ELMWOOD PARK, N.J., July 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced it will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the […]